Functional Insights of MraZ on the Pathogenicity of Staphylococcus aureus

References

• Otto M. Staphylococcus colonization of the skin and antimicrobial peptides. Expert Rev Dermatol. 2010;5(2):183–195. doi:10.1586/edm.10.620473345
   PubMedGoogle Scholar
• Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–661. doi:10.1128/CMR.00134-1426016486
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Tumbarello M, Cauda R. Staphylococcus aureus infections. N Engl J Med. 1998;339(27):2026–2027.
   Google Scholar
• Centers for Disease Control and Prevention. Active bacterial core surveillance report, emerging infections program network, methicillin-resistant Staphylococcus aureus. 2014.
   Google Scholar
• Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev. 2000;13(1):16–34, table of contents. doi:10.1128/CMR.13.1.1610627489
   PubMed Web of Science ®Google Scholar
• Risley AL, Loughman A, Cywes-Bentley C, Foster TJ, Lee JC. Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets. J Infect Dis. 2007;196(6):919–927. doi:10.1086/52093217703424
   PubMed Web of Science ®Google Scholar
• Thammavongsa V, Kim HK, Missiakas D, Schneewind O. Staphylococcal manipulation of host immune responses. Nat Rev Microbiol. 2015;13(9):529–543. doi:10.1038/nrmicro352126272408
   PubMed Web of Science ®Google Scholar
• Otto M. Staphylococcus aureus toxins. Curr Opin Microbiol. 2014;17:32–37. doi:10.1016/j.mib.2013.11.00424581690
   PubMed Web of Science ®Google Scholar
• Dickey SW, Cheung GYC, Otto M. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discov. 2017;16(7):457–471. doi:10.1038/nrd.2017.2328337021
   PubMed Web of Science ®Google Scholar
• Rasko DA, Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov. 2010;9(2):117–128. doi:10.1038/nrd301320081869
   PubMed Web of Science ®Google Scholar
• Eraso JM, Markillie LM, Mitchell HD, Taylor RC, Orr G, Margolin W. The highly conserved MraZ protein is a transcriptional regulator in Escherichia coli. J Bacteriol. 2014;196(11):2053–2066. doi:10.1128/JB.01370-1324659771
   PubMed Web of Science ®Google Scholar
• Maeda T, Tanaka Y, Takemoto N, Hamamoto N, Inui M. RNase III mediated cleavage of the coding region of mraZ mRNA is required for efficient cell division in Corynebacterium glutamicum. Mol Microbiol. 2016;99(6):1149–1166. doi:10.1111/mmi.1329526713407
   PubMed Web of Science ®Google Scholar
• Trespidi G, Scoffone VC, Barbieri G, Riccardi G, Rossi ED, Buroni S. Molecular characterization of the Burkholderia cenocepacia dcw Operon and FtsZ Interactors as new targets for novel antimicrobial design. Antibiotics. 2020;9(12):841. doi:10.3390/antibiotics9120841
   Web of Science ®Google Scholar
• Bae T, Schneewind O. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid. 2006;55(1):58–63. doi:10.1016/j.plasmid.2005.05.00516051359
   PubMed Web of Science ®Google Scholar
• Montgomery CP, Boyle-Vavra S, Roux A, Ebine K, Sonenshein AL, Daum RS. CodY deletion enhances in vivo virulence of community-associated methicillin-resistant Staphylococcus aureus clone USA300. Infect Immun. 2012;80(7):2382–2389. doi:10.1128/IAI.06172-1122526672
   PubMed Web of Science ®Google Scholar
• Collins LV, Kristian SA, Weidenmaier C, et al. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J Infect Dis. 2002;186(2):214–219. doi:10.1086/34145412134257
   PubMed Web of Science ®Google Scholar
• Farnsworth CW, Schott EM, Jensen SE, et al. Adaptive upregulation of clumping factor A (ClfA) by Staphylococcus aureus in the obese, type 2 diabetic host mediates increased virulence. Infect Immun. 2017;85(6). doi:10.1128/IAI.01005-16.
   Web of Science ®Google Scholar
• Jenul C, Horswill AR, Fischetti VA. Regulation of Staphylococcus aureus virulence. Microbiol Spectr. 2019;7(2). doi:10.1128/microbiolspec.GPP3-0031-2018
   PubMed Web of Science ®Google Scholar
• Hua L, Hilliard JJ, Shi Y, et al. Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrob Agents Chemother. 2014;58(2):1108–1117. doi:10.1128/AAC.02190-1324295977
   PubMed Web of Science ®Google Scholar
• Wang Y, Di H, Chen F, et al. Discovery of benzocycloalkane derivatives efficiently blocking bacterial virulence for the treatment of methicillin-resistant S. aureus (MRSA) infections by targeting diapophytoene desaturase (CrtN). J Med Chem. 2016;59(10):4831–4848. doi:10.1021/acs.jmedchem.6b0012227139780
   PubMed Web of Science ®Google Scholar
• Chan WT, Espinosa M, Yeo CC. Keeping the wolves at bay: antitoxins of prokaryotic type II toxin-antitoxin systems. Front Mol Biosci. 2016;3:9. doi:10.3389/fmolb.2016.0000927047942
   PubMed Web of Science ®Google Scholar
• Dienemann C, Bøggild A, Winther KS, Gerdes K, Brodersen DE. Crystal structure of the VapBC toxin–antitoxin complex from Shigella flexneri reveals a hetero-octameric DNA-binding assembly. J Mol Biol. 2011;414(5):713–722. doi:10.1016/j.jmb.2011.10.02422037005
   PubMed Web of Science ®Google Scholar
• Kyuma T, Kimura S, Hanada Y, Suzuki T, Sekimizu K, Kaito C. Ribosomal RNA methyltransferases contribute to Staphylococcus aureus virulence. Febs J. 2015;282(13):2570–2584. doi:10.1111/febs.1330225893373
   PubMed Web of Science ®Google Scholar
• Vandenesch F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect. 2012;2:12.
   PubMed Web of Science ®Google Scholar
• Cheung GYC, Bae JS, Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547–569. doi:10.1080/21505594.2021.187868833522395
   PubMed Web of Science ®Google Scholar
• Jong NW, Kessel KP, Strijp JA. Immune evasion by Staphylococcus aureus. Microbiol Spectr. 2019;7(2):7–12.
   Web of Science ®Google Scholar
• Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Götz F. Inactivation of the dlt Operon inStaphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem. 1999;274(13):8405–8410. doi:10.1074/jbc.274.13.840510085071
   PubMed Web of Science ®Google Scholar
• Cheung GY, Wang R, Khan BA, Sturdevant DE, Otto M, Payne SM. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun. 2011;79(5):1927–1935. doi:10.1128/IAI.00046-1121402769
   PubMed Web of Science ®Google Scholar
• Zielinska AK, Beenken KE, Joo HS, et al. Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J Bacteriol. 2011;193(12):2948–2958. doi:10.1128/JB.01517-1021478342
   PubMed Web of Science ®Google Scholar